Plain-English translation of NCT07030257 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This clinical trial is testing an investigational medication called in patients with advanced or metastatic solid tumors. Researchers want to learn whether this medication can slow or stop cancer growth and understand what side effects patients may experience. The trial will test different doses of the medication to find the best one to study further.
Many patients with advanced cancers have exhausted standard treatment options or cannot tolerate them due to serious side effects. This medication represents a new approach that researchers hope may help patients whose cancers have progressed or stopped responding to existing therapies.
You likely qualify if…
You likely don't qualify if…
You would take one capsule of the medication by mouth every day for as long as it appears to be helping your cancer. During the first 6 weeks, you would visit the clinic weekly for checkups and blood or urine tests. After that, clinic visits would happen every 3 weeks. Researchers will monitor how your cancer responds and watch for any side effects throughout your participation in the study.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States